IP Library Granted Patent US 11,433,123
Granted Patent B2
US 11,433,123 · App. 16/319,765 · Granted Sep 6, 2022

Sustained release cowpea mosaic virus or virus-like particle therapeutic constructs for the treatment of cancer

Inventors: Nicole F. Steinmetz (San Diego, CA); Frank Alexander Veliz (Cleveland, OH); Brylee David B. Tiu (Cleveland, OH)
Assignee: CASE WESTERN RESERVE UNIVERSITY
A61K39/0011A61K39/385A61K39/39A61K47/6901A61P35/00A61K2039/5258A61K2039/585A61K2039/622A61K2039/645B82Y5/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,433,123
App. No.
16/319,765
Granted
Sep 6, 2022
Kind
B2
Abstract

A method of treating cancer in a subject in need thereof includes administering in situ to cancer cells of the subject a nanoparticle construct that includes a plurality of cowpea mosaic virus or virus-like particles electrostatically coupled to a plurality of G4 dendrimers having a different surface charge than the cowpea mosaic virus or virus-like particles. The nanoparticle construct upon delivery to a subject can provide a sustained release of the cowpea mosaic virus or virus-like particles and/or G4 dendrimers to a cell or tissue of the subject. The cancer selected from the group consisting of melanoma, breast cancer, colon cancer, lung cancer, and ovarian cancer.

Claims (13)

1. A method of treating cancer in a subject in need thereof, the method comprising:

administering in situ to cancer cells of the subject a nanoparticle construct, the nanoparticle construct comprising:

a plurality of cowpea mosaic virus or virus-like particles and

a plurality of G4 dendrimers having a different surface charge than the cowpea mosaic virus or virus-like particles electrostatically coupled to the cowpea mosaic virus or virus-like particles, the nanoparticle construct upon in situ delivery to the subject providing a sustained release of the cowpea mosaic virus or virus-like particles and/or nanoparticles to the cancer cells, wherein the cancer is selected from the group consisting of melanoma, breast cancer, colon cancer, lung cancer, and ovarian cancer.

2. The method of claim 1 , the nanoparticle construct having a hydrodynamic radius of about 100 nm to about two microns.

3. The method of claim 1 , the nanoparticle construct upon administration to a subject disassembles in a sustained manner at physiological pH.

4. The method of claim 1 , wherein the cowpea mosaic virus or virus-like particle is a cowpea mosaic virus-like particle.

5. The method of claim 1 , the nanoparticle construct comprising alternating electrostatically coupled layers of the cowpea mosaic virus or virus-like particles and the G4 dendrimers.

6. The method of claim 5 , wherein the cowpea mosaic virus or virus-like particle is loaded with or bonded to a cargo molecule.

7. The method of claim 6 , wherein the cargo molecule is an anticancer agent.

8. The method of claim 1 , wherein the nanoparticle construct is administered proximal to a tumor in the subject.

9. The method of claim 1 , wherein the cancer is metastatic cancer.

10. The method of claim 1 , wherein the cancer is ovarian cancer.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 25, 2024
From: STEINMETZ, NICOLE F.; VELIZ, FRANK ALEXANDER; TIU, BRYLEE DAVID B.
To: CASE WESTERN RESERVE UNIVERSITY
Reel/Frame 069042/0541 →
Continuity (2)
Provisional Application 62364949 · Jul 21, 2016
Related Publication 20210275651A1 · Sep 9, 2021